Leveraging our access to a library of rapid, arrhythmia-insensitive, free-breathing CMR acquisitions that were developed and validated as part of five active NIH grants (R01HL138578, R21EB024315, R01HL151079, R21AG055954, R01HL115828), we propose to perform a rapid (25 min) free-breathing CMR in this cohort who might otherwise not be considered for CMR. Leveraging our industry partnership, we propose to characterize myocardial injury with cardiac biomarkers (hsTroponin, BNP, Galectin-3) without additional cost to this study.
|Effective start/end date||8/14/20 → 7/31/22|
- National Heart, Lung, and Blood Institute (3R01HL151079-01S1)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.